Pioglitazone increased insulin sensitivity in part by activating kinase of the receptors through indirect effect on insulin receptors and that the drug may have useful benefits in insulin resistance of type 2 diabetes[30]. The gene discussed is INSR; the disease is type 2 diabetes mellitus.